Rarely Used Hemodialysis Treatment in Encephalopathy: Case Report
Open Access
- 12 June 2025
- journal article
- Published by Saglik Bilimleri Universitesi in İzmir Tıp Fakültesi Dergisi
- Vol. 4 (2) , 63-65
Abstract
Aim: Valproic acid is an anticonvulsant and mood stabilizer used in various psychiatric and neurological conditions with a wide therapeutic window. This case report aims to emphasize that taking a drug in patients receiving psychiatric treatment can be toxic even if it is not at a toxic level. Case: A 33-year-old male patient was brought to the emergency room with complaints of decreased speech, slow movements, unresponsiveness, and blank stare for several days. According to the anamnesis taken from his father, it was learned that he had a known bipolar disorder and that his current complaints had increased for 2-3 days. Vital values were stable. The patient's laboratory and radiological examinations were within normal limits. When it was learned that valproic acid treatment had just started, drug level and ammonia level tests were requested considering the possibility of side effects. A diagnosis of hyperammonemia-induced encephalopathy was made due to high ammonia levels. Conclusion: While the treatment for valproic acid side effects is to discontinue the drug and follow up, in our patient, simply discontinuing the drug was not enough and he required hemodialysis treatment. With this case, we wanted to remind that hemodialysis can also be used in VPA-induced encephalopathy.Keywords
This publication has 8 references indexed in Scilit:
- Valproic acid–induced hyperammonemia in neuropsychiatric disorders: a 2-year clinical surveyPsychopharmacology, 2022
- A Case of Valproic-Acid Induced Hyperammonemic EncephalopathyCureus, 2021
- Valproic acid induced hyperammonemic encephalopathy: A case report (Turkish)Journal of Clinical Psychiatry, 2018
- Recurrent Hyperammonemia Associated With OlanzapineJournal of Clinical Psychopharmacology, 2017
- Risperidone, a risk factor for valproate-induced encephalopathy?General Hospital Psychiatry, 2013
- Valproic acid-induced hyperammonemic encephalopathy – a potentially fatal adverse drug reactionSpringerPlus, 2013
- Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and managementGeneral Hospital Psychiatry, 2012
- Valproate monotherapy induced-delirium due to hyperammonemia: A report of three adult cases with different types of presentationIndian Journal of Psychiatry, 2008